Progressive Care, Inc.
RXMD · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $10 | $12 | $20 | $25 |
| - Cash | $9 | $6 | $8 | $7 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $3 | $8 | $13 | $20 |
| Revenue | $13 | $15 | $14 | $12 |
| % Growth | -7.9% | 1.4% | 16.7% | – |
| Gross Profit | $2 | $1 | $2 | $4 |
| % Margin | 12.9% | 7.3% | 12.5% | 30.6% |
| EBITDA | -$8 | $0 | -$15 | -$1 |
| % Margin | -62.9% | 3.2% | -101.1% | -4.8% |
| Net Income | -$9 | -$0 | -$13 | -$1 |
| % Margin | -68.8% | -2.5% | -92% | -11.1% |
| EPS Diluted | -1.49 | -0.06 | -2.13 | -0.22 |
| % Growth | -2,400% | 97.2% | -868.2% | – |
| Operating Cash Flow | $3 | -$2 | $1 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $3 | -$2 | $1 | -$1 |